SCHEMBL25754699

SCHEMBL25754699

Cc1cccc(C)c1NS(=O)(=O)c1cc([N+](=O)[O-])ccc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.51
TBXA2R P21731 2/20 0.50
NFKBIA P25963 1/20 0.49
RELA Q04206 1/20 0.49
CYTH2 Q99418 1/20 0.49
TSHR P16473 1/20 0.49
NHERF1 O14745 1/20 0.48
MCL1 Q07820 1/20 0.48
NPC1 O15118 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PDE2A O00408 1/20 0.46
PDE5A O76074 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
ALOX15 P16050 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46
PDE4A P27815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30218132 0.87 TSHR (0.58) SMN1; SMN2L3MBTL1NFKBIARELATSHR
SCHEMBL23832700 0.87 TSHR (0.58) SMN1; SMN2L3MBTL1NFKBIARELATSHR
SCHEMBL25754766 0.83 SMN1; SMN2 (0.53) SMN1; SMN2L3MBTL1TBXA2RNFKBIARELA
SCHEMBL23833706 0.82 NHERF1 (0.49) SMN1; SMN2L3MBTL1TBXA2RCYTH2NHERF1
SCHEMBL25754683 0.82 POLB (0.57) SMN1; SMN2L3MBTL1TBXA2RMEN1KMT2A
SCHEMBL25754750 0.81 MEN1 (0.51) SMN1; SMN2L3MBTL1TBXA2RNHERF1MCL1
SCHEMBL23832738 0.81 CA12 (0.61) SMN1; SMN2L3MBTL1MCL1NPC1MEN1
SCHEMBL1805646 0.80 CA1 (0.57) SMN1; SMN2L3MBTL1NHERF1MCL1NPC1
SCHEMBL23832727 0.78 CA2 (0.48) MCL1NPC1MEN1KMT2AALDH1A1
SCHEMBL30218187 0.78 CA2 (0.48) MCL1NPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 SMN1; SMN2 405/4885L3MBTL1 2375/4885TBXA2R 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.